VistaGen Therapeutics: Interesting Prospects
October 03, 2017 at 11:54 AM EDT
VistaGen's drug AV-101 has breakthrough potential for treatment of depression and other indications.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.